Serum BDNF Levels Before Treatment Predict SSRI Response in Depression

Overview

Journal Prog Neuropsychopharmacol Biol Psychiatry

Specialty Psychiatry

Date 2011 Jul 14

PMID 21749907

Citations 65

Authors

Owen M Wolkowitz

Jessica Wolf

Wendy Shelly

Rebecca Rosser

Heather M Burke

George K Lerner

Victor I Reus

J Craig Nelson

Elissa S Epel

Synthia H Mellon

Affiliations

Soon will be listed here.

Abstract

Objectives: The "neurotrophin hypothesis" of depression posits a role of brain-derived neurotrophic factor (BDNF) in depression, although it is unknown whether BDNF is more involved in the etiology of depression or in the mechanism of action of antidepressants. It is also unknown whether pre-treatment serum BDNF levels predict antidepressant response.

Methods: Thirty un-medicated depressed subjects were treated with escitalopram (N=16) or sertraline (N=14) for 8 weeks. Twenty-five of the depressed subjects completed 8 weeks of antidepressant treatment and had analyzable data. Twenty-eight healthy controls were also studied. Serum for BDNF assay was obtained at baseline in all subjects and after 8 weeks of treatment in the depressed subjects. Depression ratings were obtained at baseline and after 8 weeks of treatment in the depressed subjects.

Results: Pre-treatment BDNF levels were lower in the depressed subjects than the controls (p=0.001) but were not significantly correlated with pre-treatment depression severity. Depression ratings improved with SSRI treatment (p<0.001), and BDNF levels increased with treatment (p=0.005). Changes in BDNF levels were not significantly correlated with changes in depression ratings. However, pre-treatment BDNF levels were directly correlated with antidepressant responses (p<0.01), and "Responders" to treatment (≥ 50% improvement in depression ratings) had higher pre-treatment BDNF levels than did "Non-responders" (p<0.05).

Conclusions: These results confirm low serum BDNF levels in un-medicated depressed subjects and confirm antidepressant-induced increases in BDNF levels, but they suggest that antidepressants do not work simply by correcting BDNF insufficiency. Rather, these findings are consistent with a permissive or facilitatory role of BDNF in the mechanism of action of antidepressants.

Citing Articles

Are BDNF and Stress Levels Related to Antidepressant Response?.

Flores-Ramos M, Vega-Rosas A, Palomera-Garfias N, Saracco-Alvarez R, Ramirez-Rodriguez G Int J Mol Sci. 2024; 25(19).

PMID: 39408702 PMC: 11476652. DOI: 10.3390/ijms251910373.

Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder.

Jarcuskova D, Tkac I, Hlavacova N, Yaluri A, Kozarova M, Habalova V BMC Psychiatry. 2024; 24(1):690.

PMID: 39407134 PMC: 11481807. DOI: 10.1186/s12888-024-06162-8.

The researcher's guide to selecting biomarkers in mental health studies.

Verhoeven J, Wolkowitz O, Barr Satz I, Conklin Q, Lamers F, Lavebratt C Bioessays. 2024; 46(10):e2300246.

PMID: 39258367 PMC: 11811959. DOI: 10.1002/bies.202300246.

Hydroalcoholic Extract of Centella asiatica and Madecassic Acid Reverse Depressive-Like Behaviors, Inflammation and Oxidative Stress in Adult Rats Submitted to Stress in Early Life.

Bertollo A, Mingoti M, de Medeiros J, da Silva G, Capoani G, Lindemann H Mol Neurobiol. 2024; 61(12):10182-10197.

PMID: 38703344 DOI: 10.1007/s12035-024-04198-1.

The role of gender differences in the outcome of juvenile social isolation: Emphasis on changes in behavioral, biochemical and expression of nitric oxide synthase genes alteration.

Bijani S, Kashfi F, Zahedi-Vanjani S, Nedaei K, Sharafi A, Kalantari-Hesari A Heliyon. 2024; 10(7):e28964.

PMID: 38617928 PMC: 11015403. DOI: 10.1016/j.heliyon.2024.e28964.

References

Schmidt H, Duman R . Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology. 2010; 35(12):2378-91. PMC: 2955759. DOI: 10.1038/npp.2010.114. View

Castren E, Voikar V, Rantamaki T . Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2006; 7(1):18-21. DOI: 10.1016/j.coph.2006.08.009. View

Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L . Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res. 2008; 43(3):247-54. PMC: 3744240. DOI: 10.1016/j.jpsychires.2008.03.014. View

Martinowich K, Manji H, Lu B . New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007; 10(9):1089-93. DOI: 10.1038/nn1971. View

Shirayama Y, Nakagawa S, Russell D, Duman R . Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002; 22(8):3251-61. PMC: 6757539. DOI: 20026292. View

Sen S, Duman R, Sanacora G . Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008; 64(6):527-32. PMC: 2597158. DOI: 10.1016/j.biopsych.2008.05.005. View

Govindarajan A, Rao B, Nair D, Trinh M, Mawjee N, Tonegawa S . Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci U S A. 2006; 103(35):13208-13. PMC: 1559778. DOI: 10.1073/pnas.0605180103. View

Gonul A, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S . Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci. 2005; 255(6):381-6. DOI: 10.1007/s00406-005-0578-6. View

Henn F, Vollmayr B . Basic pathophysiological mechanisms in depression: what are they and how might they affect the course of the illness?. Pharmacopsychiatry. 2004; 37 Suppl 2:S152-6. DOI: 10.1055/s-2004-832670. View

10.

Duman C, Schlesinger L, Kodama M, Russell D, Duman R . A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry. 2006; 61(5):661-70. DOI: 10.1016/j.biopsych.2006.05.047. View

11.

Lee H, Kim Y . Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology. 2008; 57(4):194-9. DOI: 10.1159/000149817. View

12.

Groves J . Is it time to reassess the BDNF hypothesis of depression?. Mol Psychiatry. 2007; 12(12):1079-88. DOI: 10.1038/sj.mp.4002075. View

13.

Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Gabriela Nielsen M, Placentino A . Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 2010; 11(6):763-73. DOI: 10.3109/15622971003611319. View

14.

Louie A, LEWIS T, Lannon R . Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry. 1993; 54(11):435-8. View

15.

Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H . Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 32(3):679-85. DOI: 10.1016/j.pnpbp.2007.11.011. View

16.

Ikeda Y, Yahata N, Ito I, Nagano M, Toyota T, Yoshikawa T . Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res. 2008; 101(1-3):58-66. DOI: 10.1016/j.schres.2008.01.017. View

17.

Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W . Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(5):1034-7. DOI: 10.1016/j.pnpbp.2007.03.001. View

18.

Berton O, McClung C, DiLeone R, Krishnan V, Renthal W, Russo S . Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006; 311(5762):864-8. DOI: 10.1126/science.1120972. View

19.

Kozisek M, Middlemas D, Bylund D . Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther. 2007; 117(1):30-51. DOI: 10.1016/j.pharmthera.2007.07.001. View

20.

Larsen M, Hay-Schmidt A, Ronn L, Mikkelsen J . Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Eur J Pharmacol. 2007; 578(2-3):114-22. DOI: 10.1016/j.ejphar.2007.08.050. View